SCHEMBL17855588

SCHEMBL17855588

c1ccc(-c2ccc3oc4ccc(-c5ccc(N(c6ccc(-c7ccc8oc9ccccc9c8c7)cc6)c6ccc7c(c6)-c6ccccc6C7(c6ccccc6)c6ccccc6)cc5)cc4c3c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.37
PLA2G4A P47712 4/20 0.37
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 2/20 0.35
MAPT P10636 2/20 0.35
KMT2A Q03164 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
PLA2G10 O15496 1/20 0.33
LMNA P02545 1/20 0.33
OPRK1 P41145 1/20 0.33
PDK2 Q15119 1/20 0.31
AHR P35869 1/20 0.30
PIM1 P11309 1/20 0.30
CSNK2A2 P19784 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17855445 0.99 KDM4E (0.36) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL17854477 0.99 KDM4E (0.36) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL17855551 0.99 KDM4E (0.36) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL17855520 0.99 KDM4E (0.36) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL17855871 0.98 PLA2G2A (0.37) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL17855902 0.98 PLA2G2A (0.37) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL17855736 0.98 PLA2G2A (0.37) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL17804964 0.98 KDM4E (0.36) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL17855644 0.98 KDM4E (0.35) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL17855645 0.98 KDM4E (0.35) PLA2G2APLA2G4AKDM4EMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160181525-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed
US-20160181525-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160181525-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, ESR2, CCNE2 PLA2G2A 2495/4885PLA2G4A 3219/4885KDM4E 1828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.